Enhancing Prediction for Tumor Pathologic Response to Neoadjuvant Immunochemotherapy in Locally Advanced Esophageal Cancer by Dynamic Parameters from Clinical Assessments

SIMPLE SUMMARY: Neoadjuvant immunochemotherapy (NICT) has demonstrated impressive short-term efficacy, with over half of patients experiencing significant tumor shrinkage and achieving major pathological responses (MPR). These findings highlight the pressing need for further investigation into strat...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Xin-Yun, Liu, Jun, Li, Hong-Xuan, Cai, Xu-Wei, Li, Zhi-Gang, Su, Yu-Chen, Li, Yue, Dong, Xiao-Huan, Yu, Wen, Fu, Xiao-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486879/
https://www.ncbi.nlm.nih.gov/pubmed/37686655
http://dx.doi.org/10.3390/cancers15174377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486879/
https://www.ncbi.nlm.nih.gov/pubmed/37686655
http://dx.doi.org/10.3390/cancers15174377

Ejemplares similares